Manufacturer
173 recalls in our database name B Braun Medical Inc as the manufacturing or recalling firm.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
B. Braun Medical Inc. is recalling Lactated Ringer's Injection USP (1000 mL containers) due to the presence of particulate matter. The recall affects 95,412 containers distributed nationwide.
B. Braun Medical Inc. is recalling Dextrose Injection USP 70% in 2000 mL bags nationwide due to lack of assurance of sterility and potential leakage from the diaphragm port after foil removal.
B. Braun Medical Inc. is recalling Sterile Water for Injection USP 3000 mL bags (24,928 units) distributed nationwide due to lack of assurance of sterility and potential leakage from the diaphragm port.
B. Braun Medical Inc. is recalling sodium chloride for irrigation solution (3000 mL bags) due to lack of assurance of sterility and potential leakage from the diaphragm port. Affected lots distributed nationwide have expiration dates through May 31, 2028.
B. Braun Medical Inc. is recalling Lactated Ringers Irrigation 3000 mL bags due to lack of assurance of sterility and potential leakage from the diaphragm port after foil removal.
B. Braun Hemodialysis Bloodlines may accumulate small air bubbles in the arterial line due to blood gases adhering to tubing under negative pressure. Approximately 1.17 million units have been recalled in this Class I FDA action.
B Braun is recalling hemodialysis bloodlines (Model B3-4630M4705, 4,884 units) due to potential air bubble accumulation in the arterial line. Units manufactured since August 5, 2025 are affected and were distributed in the US and Canada.
B. Braun is recalling STREAMLINE BLOODLINE SET hemodialysis devices due to potential air bubble accumulation in the arterial line. The recall affects 3,158,104 units.
B. Braun is recalling hemodialysis bloodlines (Model SL-2000M2095L) due to potential air bubble accumulation in the arterial line under negative pressure. Approximately 328,640 units distributed worldwide are affected.
B. Braun Medical is recalling hemodialysis bloodline sets due to potential air bubble accumulation in the arterial line. This Class I recall affects model SL-2010M2096 manufactured since May 25, 2025, distributed worldwide.
B. Braun has recalled hemodialysis bloodlines due to potential air bubble accumulation in the arterial line. The recall affects 4,848 units distributed nationwide and in Canada.
B. Braun is recalling 21,000 units of its 21GA WINGED INFUSION needle due to the potential for needle tips to be dull, blunt, or break during use. The defect affects subcutaneous implant procedures.
B. Braun is recalling approximately 105,550 BBraun Medical 21G X4.4CM Winged Infusion Needles due to potential for needle tips to be dull, blunt, or prone to breaking.
B. Braun has recalled 51,300 units of its 21GA Winged Infusion Set due to potential needle defects. The needle tips may be dull, blunt, difficult to advance, or prone to breaking during use.
B Braun Medical is recalling IV administration sets due to potential backflow of medication from secondary containers into primary containers and inability to prime. The defect may result in wrong medication delivery or medication delivery failure.
B Braun Medical is recalling 4,536 IV Administration Sets worldwide due to potential backflow of medication from secondary containers into primary containers and inability to prime. This could compromise safe medication delivery.
B Braun Medical Inc is recalling approximately 200,917 IV administration sets with SafeDAY components due to potential medication backflow between IV containers and blockage that may prevent line preparation.
B Braun Medical Inc recalls IV administration sets due to potential backflow of medication from secondary containers into primary containers and inability to prime.
B. Braun Medical Inc is recalling 45,288 units of IV Administration Sets due to potential backflow of medication from secondary containers into primary containers and inability to prime, which could cause improper medication delivery or line contamination.
B Braun Medical Inc is recalling 63,192 IV Administration Sets due to potential backflow of medication from secondary IV containers into primary containers and inability to prime the sets.
B Braun Medical is recalling CARESAFE IV administration sets due to potential medication backflow from secondary to primary containers and inability to prime. Approximately 4,438 units are affected worldwide.
B Braun Medical Inc is recalling approximately 12,200 IV Administration Sets worldwide due to potential backflow of medication from secondary IV containers into primary containers and inability to prime. No illnesses have been reported.
B Braun Medical Inc is recalling Outlook IV administration sets due to potential backflow of medication from secondary to primary IV containers and inability to prime. No illnesses reported.
B Braun Medical is recalling extension sets used with infusion pumps due to potential backflow of medication between IV containers and inability to prime. No injuries have been reported.
B Braun Medical Inc recalls IV Administration Sets due to potential medication backflow from secondary into primary containers and priming failure. Worldwide distribution to US, Canada, Germany, Guatemala, and Singapore.